SILVER SPRING, Md., Oct. 24, 2011 — /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration today approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.

Read the full press release here.

Advertisements